Bright Health Group Inc. BHG
We take great care to ensure that the data presented and summarized in this overview for Bright Health Group Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in BHG
Top Purchases
Top Sells
About BHG
Bright Health Group, Inc., a healthcare company, provides health insurance policies in the United States. It operates in two segments, NeueHealth and Bright HealthCare. The NeueHealth segment delivers virtual and in-person clinical care services to patients under contracts through its owned and affiliated primary care clinics. As of December 31, 2021, it worked with approximately 260,000 care provider partners; and operated 180 managed and affiliated risk-bearing clinics within its integrated care delivery system, which included embedded pharmacy, laboratory, radiology, and population health focused specialty services. The Bright HealthCare segment offers commercial and medicare health plan products to consumers in 14 states and 99 markets. The company was formerly known as Bright Health Inc. and changed its name to Bright Health Group, Inc. in February 2021. Bright Health Group, Inc. was incorporated in 2015 and is headquartered in Minneapolis, Minnesota.
Insider Transactions at BHG
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|
Mar 14
2025
|
Jeffrey J Scherman Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
353
-2.8%
|
$2,118
$6.13 P/Share
|
|
Mar 14
2025
|
George Lawrence Mikan Iii CEO & President |
SELL
Open market or private sale
|
Direct |
12,440
-4.75%
|
$74,640
$6.13 P/Share
|
|
Mar 14
2025
|
Jay Matushak Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,542
-3.71%
|
$9,252
$6.13 P/Share
|
|
Mar 14
2025
|
Tomas Orozco EVP, Consumer Care |
SELL
Open market or private sale
|
Direct |
1,226
-4.01%
|
$7,356
$6.13 P/Share
|
|
Mar 14
2025
|
Jeffery Michael Craig GC & Corporate Secretary |
SELL
Open market or private sale
|
Direct |
899
-4.28%
|
$5,394
$6.13 P/Share
|
|
Mar 13
2025
|
Jeffrey J Scherman Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,020
-7.5%
|
$6,120
$6.74 P/Share
|
|
Mar 13
2025
|
George Lawrence Mikan Iii CEO & President |
SELL
Open market or private sale
|
Direct |
35,896
-12.05%
|
$215,376
$6.74 P/Share
|
|
Mar 13
2025
|
Jay Matushak Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,448
-9.66%
|
$26,688
$6.74 P/Share
|
|
Mar 13
2025
|
Tomas Orozco EVP, Consumer Care |
SELL
Open market or private sale
|
Direct |
3,540
-10.38%
|
$21,240
$6.74 P/Share
|
|
Mar 13
2025
|
Jeffery Michael Craig GC & Corporate Secretary |
SELL
Open market or private sale
|
Direct |
2,595
-11.0%
|
$15,570
$6.74 P/Share
|
|
Mar 12
2025
|
Jeffrey J Scherman Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
375
-2.68%
|
$2,250
$6.93 P/Share
|
|
Mar 12
2025
|
Jeffery Michael Craig GC & Corporate Secretary |
SELL
Open market or private sale
|
Direct |
953
-3.88%
|
$5,718
$6.93 P/Share
|
|
Mar 12
2025
|
George Lawrence Mikan Iii CEO & President |
SELL
Open market or private sale
|
Direct |
13,180
-4.24%
|
$79,080
$6.93 P/Share
|
|
Mar 12
2025
|
Jay Matushak Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,633
-3.43%
|
$9,798
$6.93 P/Share
|
|
Mar 12
2025
|
Jay Matushak Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+33.49%
|
-
|
|
Mar 12
2025
|
Tomas Orozco EVP, Consumer Care |
SELL
Open market or private sale
|
Direct |
1,300
-3.67%
|
$7,800
$6.93 P/Share
|
|
Mar 11
2025
|
Jeffrey J Scherman Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+28.23%
|
-
|
|
Mar 11
2025
|
Jeffrey J Scherman Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
427
-4.79%
|
$2,562
$6.85 P/Share
|
|
Mar 11
2025
|
Jeffery Michael Craig GC & Corporate Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+36.32%
|
-
|
|
Mar 11
2025
|
Jeffery Michael Craig GC & Corporate Secretary |
SELL
Open market or private sale
|
Direct |
195
-1.81%
|
$1,170
$6.85 P/Share
|
Last 12 Months Summary
| Exercise of conversion of derivative security | 488K shares |
|---|
| Open market or private sale | 179K shares |
|---|